Q-Immune, Inc.

SEC filing

Biotechnology · Seattle, WA

Form D on EDGAR

Amount raised$25Ksold at filing

Total offering$1M$975K still open

Investors in the raise1count reported to the SEC

FiledSep 28, 2026first sale Sep 24, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Stephen Paucha SmithExecutive Officer, Director

Cameron McCannExecutive Officer, Director, Promoter

Executive officers, directors and promoters as listed on the Form D.